Phase (Ph) 1/2a study of CLN-081 in patients (pts) with NSCLC with EGFR exon 20 insertion mutations (Ins20).
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Helena Alexandra Yu, Daniel Shao-Weng Tan, Egbert F. Smit, Alexander I. Spira, Ross A. Soo, Danny Nguyen, Victor Ho-Fun Lee, James Chih-Hsin Yang, Vamsidhar Velcheti, John M. Wrangle, Mark A. Socinski, Marianna Koczywas, David Witter, Asher Page, Leigh Zawel, John Edward Janik, Zofia Piotrowska
Institutions: Memorial Sloan Kettering Cancer Center, National Cancer Centre Singapore, The Netherlands Cancer Institute, National University Hospital, City Of Hope National Medical Center, Queen Mary Hospital, University of Hong Kong, National Taiwan University Hospital, Cleveland Clinic, Johns Hopkins University, AdventHealth Orlando, Cullinan Oncology (United States), Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281742019